Our study demonstrated that the prevalence of the p.Ala91Val missense variant in the PRF1 gene was nearly twofold greater among young-onset BRCA1-driven BC patients than among late-onset patients (4.9% vs. 2.2%). This evidence concerns the gene PRF1 and breast cancer.